Latest News about CRSP
Recent news which mentions CRSP
2 Top Biotech Stocks to Buy in October
October 03, 2023
From Motley Fool
Better Gene Editing Stock: Editas Medicine vs. CRISPR Therapeutics
October 02, 2023
From Motley Fool
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
October 01, 2023
From Motley Fool
3 Cathie Wood Stocks Set to Explode Higher
October 01, 2023
From InvestorPlace
Futurescape: Betting Big on These 3 Next-Gen Tech Stocks
October 01, 2023
From InvestorPlace
3 No-Brainer Growth Stocks to Buy in October
October 01, 2023
From Motley Fool
Editas Medicine Is Beyond Skepticism, Analyst Has Confidence In Sickle Cell Therapy, Upgrades Stock
September 29, 2023
From Benzinga
Why Editas Medicine Stock Is Soaring Today
September 29, 2023
From Motley Fool
If I Could Only Buy 3 Stocks in 2023, I'd Pick These
September 29, 2023
From Motley Fool
2 Bargain Growth Stocks to Buy Hand Over Fist
September 28, 2023
From Motley Fool
Don’t Miss the Boom: 3 Pharma Stocks Set to Explode Higher
September 27, 2023
From InvestorPlace
From Dust to Diamonds: 7 Undervalued Stocks With Sparkling Prospects
September 27, 2023
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023
September 27, 2023
From Benzinga
2 Cathie Wood Stocks to Buy Hand Over Fist Right Now
September 24, 2023
From Motley Fool
$10,000 Invested in These Growth Stocks Could Make You a Fortune Over the Next 10 Years
September 21, 2023
From Motley Fool
Better Growth Stock: CRISPR Therapeutics vs. Bluebird Bio
September 20, 2023
From Motley Fool
Where Will CRISPR Therapeutics Be in 5 Years?
September 19, 2023
From Motley Fool
1 Huge Risk That Gene-Editing Stock Investors Desperately Need to Know
September 19, 2023
From Motley Fool
2 Top Trends to Invest $500 In Right Now
September 18, 2023
From Motley Fool
Looking for Growth? These Companies' Revenue May Skyrocket
September 17, 2023
From Motley Fool
If You Invested $30,000 in CRISPR Therapeutics in 2016, This Is How Much You Would Have Today
September 16, 2023
From Motley Fool
Better Growth Stock: Recursion Pharmaceuticals vs. CRISPR Therapeutics
September 15, 2023
From Motley Fool
3 Top Healthcare Stocks Defying the Bear Market
September 15, 2023
From Motley Fool
Better Bull Market Buy: CRISPR vs. Medtronic Stock
September 14, 2023
From Motley Fool
3 Biotech Blockbusters to Turn $5,000 Into $50,000
September 12, 2023
From InvestorPlace
More Likely to 5x First: Bluebird Bio vs. CRISPR Therapeutics
September 12, 2023
From Motley Fool
2 No-Brainer Biotech Stocks to Buy Right Now
September 12, 2023
From Motley Fool
CRSP Stock Alert: What to Know as CRISPR Therapeutics Co-Founder Steps Down
September 07, 2023
From InvestorPlace
From Motley Fool
With a Prediction for a 70% Gain, Is Wall Street Too Optimistic About This Biotech Stock?
September 05, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.